Ptip Safeguards the Epigenetic Control of Skeletal Stem Cell Quiescence and Potency in Skeletogenesis

Jianfei Liang,Jing Wang,Bingdong Sui,Yibo Tong,Jihua Chai,Qin Zhou,Chenxi Zheng,Hao Wang,Liang Kong,Haojian Zhang,Yi Bai
DOI: https://doi.org/10.1016/j.scib.2024.02.036
IF: 18.9
2024-01-01
Science Bulletin
Abstract:Stem cells remain in a quiescent state for long-term maintenance and preservation of potency; this process requires fine-tuning regulatory mechanisms. In this study, we identified the epigenetic landscape along the developmental trajectory of skeletal stem cells (SSCs) in skeletogenesis governed by a key regulator, Ptip (also known as Paxip1, Pax interaction with transcription-activation domain protein-1). Our results showed that Ptip is required for maintaining the quiescence and potency of SSCs, and loss of Ptip in type II collagen (Col2)+ progenitors causes abnormal activation and differentiation of SSCs, impaired growth plate morphogenesis, and long bone dysplasia. We also found that Ptip suppressed the glycolysis of SSCs through downregulation of phosphoglycerate kinase 1 (Pgk1) by repressing histone H3 lysine 27 acetylation (H3K27ac) at the promoter region. Notably, inhibition of glycolysis improved the function of SSCs despite Ptip deficiency. To the best of our knowledge, this is the first study to establish an epigenetic framework based on Ptip, which safeguards skeletal stem cell quiescence and potency through metabolic control. This framework is expected to improve SSC-based treatments of bone developmental disorders.
What problem does this paper attempt to address?